- Kidney Proximal Tubular Ultrastructural Changes Precede Albuminuria in Type 1 Diabetes
10:00 AM - 12:00 PM
Kidney Proximal Tubular Ultrastructural Changes Precede Albuminuria in Type 1 Diabetes
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Kidney Hemodynamic Function in Historic vs. Contemporary Patients with Type 1 Diabetes
10:00 AM - 12:00 PM
Kidney Hemodynamic Function in Historic vs. Contemporary Patients with Type 1 Diabetes
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Profiles of Circulating MicroRNAs Associated with the Development of ESKD in Diabetes
10:00 AM - 12:00 PM
Profiles of Circulating MicroRNAs Associated with the Development of ESKD in Diabetes
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Predictive Value of Established and Novel Biomarkers for Kidney Outcomes in CKD: A Comparative Validation Study
10:00 AM - 12:00 PM
Predictive Value of Established and Novel Biomarkers for Kidney Outcomes in CKD: A Comparative Validation Study
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Intraindividual Variability of Urinary Epidermal Growth Factor and Clusterin and Effect of Frozen Storage on Stability: Results from UVALID
10:00 AM - 12:00 PM
Intraindividual Variability of Urinary Epidermal Growth Factor and Clusterin and Effect of Frozen Storage on Stability: Results from UVALID
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Urinary Immature Truncated O-glycans Correlate with Glomerular and Tubulointerstitial Severity of Biopsy-Proven Diabetic Kidney Disease
10:00 AM - 12:00 PM
Urinary Immature Truncated O-glycans Correlate with Glomerular and Tubulointerstitial Severity of Biopsy-Proven Diabetic Kidney Disease
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Urinary Lipid Metabolites and Progression of Kidney Disease in Individuals with Type 2 Diabetes
10:00 AM - 12:00 PM
Urinary Lipid Metabolites and Progression of Kidney Disease in Individuals with Type 2 Diabetes
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Baseline and One-Year Percent Changes in Concentration of Plasma Proteins as Predictors of ESKD in the Chronic Renal Insufficiency Cohort (CRIC) with Type 2 Diabetes
10:00 AM - 12:00 PM
Baseline and One-Year Percent Changes in Concentration of Plasma Proteins as Predictors of ESKD in the Chronic Renal Insufficiency Cohort (CRIC) with Type 2 Diabetes
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Bioenergetic Shifts in Plasma Amino Acids and Related Metabolites in Response to SGLT2 Inhibition and Hyperglycemia in Type 1 Diabetes
10:00 AM - 12:00 PM
Bioenergetic Shifts in Plasma Amino Acids and Related Metabolites in Response to SGLT2 Inhibition and Hyperglycemia in Type 1 Diabetes
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Analysis of the Relationship Between Serum Nesfatin-1 Concentration and Diabetic Nephropathy Disease Activity Factors
10:00 AM - 12:00 PM
Analysis of the Relationship Between Serum Nesfatin-1 Concentration and Diabetic Nephropathy Disease Activity Factors
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Increased Body Mass Index Variability as an Independent Predictor of Diabetic Kidney Disease Progression
10:00 AM - 12:00 PM
Increased Body Mass Index Variability as an Independent Predictor of Diabetic Kidney Disease Progression
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Impact of Longer Diabetes Duration and eGFR on Cardiovascular Complications and Mortality
10:00 AM - 12:00 PM
Impact of Longer Diabetes Duration and eGFR on Cardiovascular Complications and Mortality
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Sex Hormones and Risk of CKD Progression Among Adults with Type 2 Diabetes and Obesity in the Look AHEAD Sex Hormone Ancillary Study
10:00 AM - 12:00 PM
Sex Hormones and Risk of CKD Progression Among Adults with Type 2 Diabetes and Obesity in the Look AHEAD Sex Hormone Ancillary Study
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Phenome-Wide Association Study of Kidney Volume in a General Population Biobank Stratified by Diabetes Status
10:00 AM - 12:00 PM
Phenome-Wide Association Study of Kidney Volume in a General Population Biobank Stratified by Diabetes Status
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Comparison of the Risk for Proteinuria Among SGLT2 Inhibitors in Patients with Diabetes Without Current Urinary Protein
10:00 AM - 12:00 PM
Comparison of the Risk for Proteinuria Among SGLT2 Inhibitors in Patients with Diabetes Without Current Urinary Protein
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Effect of SGLT2 Inhibition (SGLT2i) on Blood and Urinary Biomarkers of Cardiovascular and Kidney Disease in Patients with Advanced Diabetic Kidney Disease (DKD)
10:00 AM - 12:00 PM
Effect of SGLT2 Inhibition (SGLT2i) on Blood and Urinary Biomarkers of Cardiovascular and Kidney Disease in Patients with Advanced Diabetic Kidney Disease (DKD)
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Effect of Semaglutide on Hemoglobin A1c and Body Weight Change by CKD Stage: Post Hoc Analysis from the FLOW Trial
10:00 AM - 12:00 PM
Effect of Semaglutide on Hemoglobin A1c and Body Weight Change by CKD Stage: Post Hoc Analysis from the FLOW Trial
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- GLP-1 Receptor Agonists Reduce Dementia and Alzheimer Disease Risk in Patients with Diabetes and Advanced CKD: Real-World Evidence from TriNetX
10:00 AM - 12:00 PM
GLP-1 Receptor Agonists Reduce Dementia and Alzheimer Disease Risk in Patients with Diabetes and Advanced CKD: Real-World Evidence from TriNetX
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- GLP-1 Receptor Agonist Use and Kidney Outcomes in Patients with Cancer and Type 2 Diabetes: Real-World Global Matched Cohort Analysis
10:00 AM - 12:00 PM
GLP-1 Receptor Agonist Use and Kidney Outcomes in Patients with Cancer and Type 2 Diabetes: Real-World Global Matched Cohort Analysis
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- GLP-1 Receptor Agonists Target Autophagy Dysfunction in Diabetic Nephropathy
10:00 AM - 12:00 PM
GLP-1 Receptor Agonists Target Autophagy Dysfunction in Diabetic Nephropathy
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Evaluating the Safety and Efficacy of GLP-1 Receptor Agonists in Kidney Transplant Recipients with Diabetic Nephropathy
10:00 AM - 12:00 PM
Evaluating the Safety and Efficacy of GLP-1 Receptor Agonists in Kidney Transplant Recipients with Diabetic Nephropathy
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Kidney, Cardiovascular, and Death Outcomes with Semaglutide Treatment Among Two Race and Two Ethnic Groups: Post Hoc Analysis from the FLOW Trial
10:00 AM - 12:00 PM
Kidney, Cardiovascular, and Death Outcomes with Semaglutide Treatment Among Two Race and Two Ethnic Groups: Post Hoc Analysis from the FLOW Trial
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Fragility Index of SGLT2 Inhibitor, GLP-1 Receptor Agonist, and Nonsteroidal Mineralocorticoid Receptor Antagonist (nsMRA) Clinical Trials for Kidney and Cardiovascular Protection
10:00 AM - 12:00 PM
Fragility Index of SGLT2 Inhibitor, GLP-1 Receptor Agonist, and Nonsteroidal Mineralocorticoid Receptor Antagonist (nsMRA) Clinical Trials for Kidney and Cardiovascular Protection
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Sex Differences in SGLT2 Inhibitor Use Complicating a Treatment Optimization Program in a Large Network of Nephrology Practices
10:00 AM - 12:00 PM
Sex Differences in SGLT2 Inhibitor Use Complicating a Treatment Optimization Program in a Large Network of Nephrology Practices
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- A Case of Probable Empagliflozin-Induced Psoriasis in a Patient with Diabetic Kidney Disease
10:00 AM - 12:00 PM
A Case of Probable Empagliflozin-Induced Psoriasis in a Patient with Diabetic Kidney Disease
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- GLP-1 Receptor Agonists and Serious Adverse Events of Hyperkalemia/Hypokalemia: Systematic Review and Meta-Analysis
10:00 AM - 12:00 PM
GLP-1 Receptor Agonists and Serious Adverse Events of Hyperkalemia/Hypokalemia: Systematic Review and Meta-Analysis
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Efficacy of Finerenone Combined with SGLT2 Inhibitors in the Treatment of Diabetic Kidney Disease
10:00 AM - 12:00 PM
Efficacy of Finerenone Combined with SGLT2 Inhibitors in the Treatment of Diabetic Kidney Disease
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Efficacy and Safety of Finerenone in Biopsy-Proven CKD Associated with Type 2 Diabetes: A Single-Center, Single-Arm Real-World Study
10:00 AM - 12:00 PM
Efficacy and Safety of Finerenone in Biopsy-Proven CKD Associated with Type 2 Diabetes: A Single-Center, Single-Arm Real-World Study
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Clinical Efficacy of Finerenone in Diabetic Kidney Disease: A Retrospective Cohort Study
10:00 AM - 12:00 PM
Clinical Efficacy of Finerenone in Diabetic Kidney Disease: A Retrospective Cohort Study
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Impact of Finerenone on Kidney Function, Albuminuria, and Arterial Stiffness: Clinical Insights from a Pilot Six-Month Diabetic Kidney Disease Study
10:00 AM - 12:00 PM
Impact of Finerenone on Kidney Function, Albuminuria, and Arterial Stiffness: Clinical Insights from a Pilot Six-Month Diabetic Kidney Disease Study
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Therapeutic Efficacy of Finerenone and Risk Factors for Kidney Function Changes in Early Stage for Patients with Type 2 Diabetes and CKD
10:00 AM - 12:00 PM
Therapeutic Efficacy of Finerenone and Risk Factors for Kidney Function Changes in Early Stage for Patients with Type 2 Diabetes and CKD
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Finerenone Use in Patients with Diabetes and CKD
10:00 AM - 12:00 PM
Finerenone Use in Patients with Diabetes and CKD
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Real-World Effects of Finerenone in Diabetic Kidney Disease: Data from Turkish Multicenter Cohort (FINE-TURK Study)
10:00 AM - 12:00 PM
Real-World Effects of Finerenone in Diabetic Kidney Disease: Data from Turkish Multicenter Cohort (FINE-TURK Study)
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Combinations of Renin-Angiotensin-Aldosterone System Inhibitors, Statins, SGLT2 Inhibitors, and GLP-1 Receptor Agonists and Survival
10:00 AM - 12:00 PM
Combinations of Renin-Angiotensin-Aldosterone System Inhibitors, Statins, SGLT2 Inhibitors, and GLP-1 Receptor Agonists and Survival
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Combination Treatment for Cardiorenal Protection in US Adults
10:00 AM - 12:00 PM
Combination Treatment for Cardiorenal Protection in US Adults
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- National Trends in Use of CKD Guideline-Directed Medical Therapies
10:00 AM - 12:00 PM
National Trends in Use of CKD Guideline-Directed Medical Therapies
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Safety and Feasibility of Simultaneous and Gradual Initiation of Combination Renoprotective Therapy in Patients with Type 2 Diabetes and CKD: A Real-World Analysis
10:00 AM - 12:00 PM
Safety and Feasibility of Simultaneous and Gradual Initiation of Combination Renoprotective Therapy in Patients with Type 2 Diabetes and CKD: A Real-World Analysis
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.